SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001082327-05-000033
Filing Date
2005-02-14
Accepted
2005-02-11 17:56:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 FT 13GA1 GUILFORD PHARMACEUTICAL 12.31.04 r13ga-guilford12312004.txt SC 13G/A 5847
  Complete submission text file 0001082327-05-000033.txt   7859
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45277 | Film No.: 05600665
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 BOREL AVENUE, SUITE 402 SAN MATEO CA 94402
Business Address 411 BOREL AVENUE, SUITE 402 SAN MATEO CA 94402 6505728334
FULLER & THALER ASSET MANAGEMENT, INC. (Filed by) CIK: 0001082327 (see all company filings)

IRS No.: 943176968 | Fiscal Year End: 1231
Type: SC 13G/A